BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 36474188)

  • 1. Speckle-type POZ protein could play a potential inhibitory role in human renal cell carcinoma.
    Chen Z; Li Z; Li C; Li B; Wang H; Nong D; Li X; Huang G; Lin J; Li W
    BMC Cancer; 2022 Dec; 22(1):1277. PubMed ID: 36474188
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Speckle-type POZ protein up-regulates c-Jun protein expression and promotes proliferation and invasion of renal carcinoma cells].
    Wu L; Yu K; Cue Y; Zhu X; Yang Z; Ma J
    Nan Fang Yi Ke Da Xue Xue Bao; 2021 Mar; 41(3):447-452. PubMed ID: 33849838
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SPOP promotes tumor progression via activation of β-catenin/TCF4 complex in clear cell renal cell carcinoma.
    Zhao W; Zhou J; Deng Z; Gao Y; Cheng Y
    Int J Oncol; 2016 Sep; 49(3):1001-8. PubMed ID: 27572476
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Properties and Clinical Relevance of Speckle-Type POZ Protein in Human Colorectal Cancer.
    Xu J; Wang F; Jiang H; Jiang Y; Chen J; Qin J
    J Gastrointest Surg; 2015 Aug; 19(8):1484-96. PubMed ID: 26022775
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Small-Molecule Targeting of E3 Ligase Adaptor SPOP in Kidney Cancer.
    Guo ZQ; Zheng T; Chen B; Luo C; Ouyang S; Gong S; Li J; Mao LL; Lian F; Yang Y; Huang Y; Li L; Lu J; Zhang B; Zhou L; Ding H; Gao Z; Zhou L; Li G; Zhou R; Chen K; Liu J; Wen Y; Gong L; Ke Y; Yang SD; Qiu XB; Zhang N; Ren J; Zhong D; Yang CG; Liu J; Jiang H
    Cancer Cell; 2016 Sep; 30(3):474-484. PubMed ID: 27622336
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Speckle-type POZ protein as a diagnostic biomarker in renal cell carcinoma.
    Chauhan A; Bhattacharyya S; Ojha R; Mandal AK; Singh SK
    J Cancer Res Ther; 2018; 14(5):977-982. PubMed ID: 30197334
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The E2F1-miR-520/372/373-SPOP Axis Modulates Progression of Renal Carcinoma.
    Ding M; Lu X; Wang C; Zhao Q; Ge J; Xia Q; Wang J; Zen K; Zhang CY; Zhang C
    Cancer Res; 2018 Dec; 78(24):6771-6784. PubMed ID: 30348808
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SPOP suppresses tumorigenesis by regulating Hedgehog/Gli2 signaling pathway in gastric cancer.
    Zeng C; Wang Y; Lu Q; Chen J; Zhang J; Liu T; Lv N; Luo S
    J Exp Clin Cancer Res; 2014 Sep; 33(1):75. PubMed ID: 25204354
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SPOP promotes ATF2 ubiquitination and degradation to suppress prostate cancer progression.
    Ma J; Chang K; Peng J; Shi Q; Gan H; Gao K; Feng K; Xu F; Zhang H; Dai B; Zhu Y; Shi G; Shen Y; Zhu Y; Qin X; Li Y; Zhang P; Ye D; Wang C
    J Exp Clin Cancer Res; 2018 Jul; 37(1):145. PubMed ID: 29996942
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of SIRT1/AMPK signaling in the proliferation, migration and invasion of renal cell carcinoma cells.
    Wang X; Lu Y; Tuo Z; Zhou H; Zhang Y; Cao Z; Peng L; Yu D; Bi L
    Oncol Rep; 2021 Jun; 45(6):. PubMed ID: 33907836
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Deregulation of SPOP in Cancer.
    Zhang H; Jin X; Huang H
    Cancer Res; 2023 Feb; 83(4):489-499. PubMed ID: 36512624
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Downregulation of CLDN7 due to promoter hypermethylation is associated with human clear cell renal cell carcinoma progression and poor prognosis.
    Li Y; Gong Y; Ning X; Peng D; Liu L; He S; Gong K; Zhang C; Li X; Zhou L
    J Exp Clin Cancer Res; 2018 Nov; 37(1):276. PubMed ID: 30428910
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SPOP promotes CDCA5 degradation to regulate prostate cancer progression via the AKT pathway.
    Luo Z; Wang J; Zhu Y; Sun X; He C; Cai M; Ma J; Wang Y; Han S
    Neoplasia; 2021 Oct; 23(10):1037-1047. PubMed ID: 34509929
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Loss of Speckle-Type POZ Protein Promotes Prostate Cancer Cell Migration and Invasion Through Upregulation of MCP-1.
    Shi J; Cao J; Lu X; Fan L; Guo H; Fu J
    Med Sci Monit; 2021 Apr; 27():e929199. PubMed ID: 33872295
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decreased expression of the SPOP gene is associated with poor prognosis in glioma.
    Ding D; Song T; Jun W; Tan Z; Fang J
    Int J Oncol; 2015 Jan; 46(1):333-41. PubMed ID: 25351530
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vitamin D receptor suppresses proliferation and metastasis in renal cell carcinoma cell lines via regulating the expression of the epithelial Ca2+ channel TRPV5.
    Chen Y; Liu X; Zhang F; Liao S; He X; Zhuo D; Huang H; Wu Y
    PLoS One; 2018; 13(4):e0195844. PubMed ID: 29659618
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Speckle-type POZ protein suppresses hepatocellular carcinoma cell migration and invasion via ubiquitin-dependent proteolysis of SUMO1/sentrin specific peptidase 7.
    Ji P; Liang S; Li P; Xie C; Li J; Zhang K; Zheng X; Feng M; Li Q; Jiao H; Chi X; Zhao W; Zhang S; Wang X
    Biochem Biophys Res Commun; 2018 Jul; 502(1):30-42. PubMed ID: 29777712
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SPOP suppresses pancreatic cancer progression by promoting the degradation of NANOG.
    Tan P; Xu Y; Du Y; Wu L; Guo B; Huang S; Zhu J; Li B; Lin F; Yao L
    Cell Death Dis; 2019 Oct; 10(11):794. PubMed ID: 31624231
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Speckle-type POZ protein is negatively associated with malignancies and inhibits cell proliferation and migration in liver cancer.
    Huang Y; Tan N; Jia D; Jing Y; Wang Q; Li Z; Zhang J; Liu L; Li J; Chen Z; He X
    Tumour Biol; 2015 Dec; 36(12):9753-61. PubMed ID: 26156804
    [TBL] [Abstract][Full Text] [Related]  

  • 20. BTB/POZ domain of speckle-type POZ protein (SPOP) confers proapoptotic function in HeLa cells.
    Byun B; Tak H; Joe CO
    Biofactors; 2007; 31(3-4):165-9. PubMed ID: 18997279
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.